Association of coagulation disturbances with severity of COVID-19: a longitudinal study

Huimin Lu1, Ming Chen1, Shaoqiu Tang2

  • 1Department of Intensive Care Unit, Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital, Nanjing, People's Republic of China.

Insights

Severe COVID-19 patients exhibit significant hypercoagulability, with elevated activated partial thromboplastin time (APTT), D-dimer, and fibrinogen. These coagulation changes in severe cases may link to early inflammation, unlike in non-severe cases.

Area of Science:

  • Medical research
  • Hematology
  • Infectious diseases

Background:

  • Coagulation dysfunction is a key factor in COVID-19 patient care, even with normal inflammation.
  • Understanding coagulation changes is crucial for managing COVID-19.

Purpose of the Study:

  • To analyze coagulation function indices in COVID-19 patients.
  • To compare coagulation characteristics between non-severe and severe COVID-19 cases.
  • To investigate potential mechanisms of coagulation dysfunction in COVID-19.

Main Methods:

  • Included 143 COVID-19 patients.
  • Collected clinical characteristics, coagulation function, and inflammatory factor data.
  • Compared indices based on disease severity (non-severe vs. severe).

Main Results:

  • Severe COVID-19 patients showed significantly higher APTT, D-dimer, and fibrinogen levels.
  • In severe cases, all three indices exceeded normal ranges and correlated with early inflammation.
  • Non-severe patients showed increasing trends, with only fibrinogen above normal, and no correlation with inflammation.

Conclusions:

  • Severe COVID-19 patients display more evident hypercoagulability.
  • Coagulation changes in severe COVID-19 may relate to early inflammatory factor increases.
  • Other factors likely contribute to abnormal coagulation in non-severe COVID-19 patients.
Abstract

Related Concept Videos

Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.2K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.4K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
74
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.8K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
128
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
48